Symbols / VRCA Stock $5.98 +9.32% Verrica Pharmaceuticals Inc.

Healthcare • Biotechnology • United States • NCM
VRCA (Stock) Chart
About

Verrica Pharmaceuticals Inc., a dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States. The company offers YCANTH (VP-102) a drug-device combination that contains a GMP-controlled formulation of cantharidin for the treatment of molluscum in adult and pediatric patients, as well as for the treatment of common warts. It also develops VP-315, an oncolytic peptide-based injectable therapy that is in phase II clinical trial for the treatment of dermatology oncologic conditions, which include basal cell carcinoma and other dermatological oncology indications. The company has a collaboration and license agreement with Torii Pharmaceutical Co., Ltd. for the development and commercialization of its product candidates for the treatment of molluscum and common warts in Japan; and a license agreement with Lytix Biopharma AS to develop and commercialize VP-315 for use in malignant and pre-malignant dermatological indications. Verrica Pharmaceuticals Inc. was incorporated in 2013 and is headquartered in West Chester, Pennsylvania.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 102.73M
Enterprise Value 65.45M Income -17.89M Sales 35.58M
Book/sh 1.44 Cash/sh 1.75 Dividend Yield —
Payout 0.00% Employees 76 IPO —
P/E — Forward P/E -3.51 PEG —
P/S 2.89 P/B 4.15 P/C —
EV/EBITDA -5.71 EV/Sales 1.84 Quick Ratio 2.16
Current Ratio 2.59 Debt/Eq 6.59 LT Debt/Eq —
EPS (ttm) -1.68 EPS next Y -1.71 EPS Growth —
Revenue Growth 13.80% Earnings 2026-05-13 ROA -14.74%
ROE -240.36% ROIC — Gross Margin 65.44%
Oper. Margin -136.41% Profit Margin -50.27% Shs Outstand 17.18M
Shs Float 6.78M Short Float 3.66% Short Ratio 3.58
Short Interest — 52W High 9.82 52W Low 3.28
Beta 1.43 Avg Volume 140.73K Volume 75.39K
Target Price $16.50 Recom None Prev Close $5.47
Price $5.98 Change 9.32%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$16.50
Mean price target
2. Current target
$5.98
Latest analyst target
3. DCF / Fair value
$-16.20
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$5.98
Low
$10.00
High
$20.00
Mean
$16.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-12-18 up Brookline Capital Hold → Buy $17
2025-05-14 reit Needham Hold → Hold —
2025-04-09 reit Needham Hold → Hold —
2025-04-08 reit HC Wainwright & Co. Neutral → Neutral —
2025-03-12 reit Needham Hold → Hold —
2024-12-20 reit Needham Hold → Hold —
2024-11-06 down HC Wainwright & Co. Buy → Neutral —
2024-11-05 reit Needham — → Hold —
2024-11-05 down RBC Capital Outperform → Sector Perform $2
2024-10-21 main TD Cowen Buy → Buy $10
2024-10-04 main RBC Capital Outperform → Outperform $11
2024-10-03 down Needham Buy → Hold $12
2024-10-02 down Brookline Capital Buy → Hold —
2024-08-15 main RBC Capital Outperform → Outperform $13
2024-08-15 main Needham Buy → Buy $12
2024-05-16 reit Needham Buy → Buy $16
2024-05-14 main HC Wainwright & Co. Buy → Buy $14
2024-05-14 main Needham Buy → Buy $16
2024-04-10 reit Needham Buy → Buy $8
2024-03-01 reit Needham Buy → Buy $8
News
RSS: Latest VRCA news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-23 KIRBY JOHN J. Chief Financial Officer — 10,000 $0.00 $0
2025-11-25 MANNING PAUL B. Director and Beneficial Owner of more than 10% of a Class of Security — 4,126,142 $4.24 $17,505,157
2025-11-25 KIRBY JOHN J. Chief Financial Officer — 3,536 $4.24 $15,001
2025-11-25 ROSENBERG NOAH L Officer — 2,357 $4.24 $10,000
2025-11-25 RIEGER JAYSON Chief Executive Officer — 94,311 $4.24 $400,114
2025-11-25 ZAWITZ DAVID Chief Operating Officer — 10,000 $4.24 $42,425
2025-03-17 HAYES CHRISTOPHER G Officer — 4,315 $0.65 $2,805
2024-11-26 MANNING PAUL B. Director and Beneficial Owner of more than 10% of a Class of Security — 450,000 $0.00 $0
2024-11-22 MANNING PAUL B. Director and Beneficial Owner of more than 10% of a Class of Security — 22,921,348 $0.99 $22,795,281
2024-11-22 STALFORT JOHN A Director — 1,123,595 $0.99 $1,117,415
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
35.58
+370.22%
7.57
+47.66%
5.12
-43.27%
9.03
Operating Revenue
35.58
+370.22%
7.57
+47.66%
5.12
-43.27%
9.03
Cost Of Revenue
3.44
+25.58%
2.74
+267.29%
0.75
+2.90%
0.72
Reconciled Cost Of Revenue
3.44
+25.58%
2.74
+267.29%
0.75
+2.90%
0.72
Gross Profit
32.14
+565.89%
4.83
+10.23%
4.38
-47.30%
8.31
Operating Expense
44.08
-37.63%
70.66
+4.53%
67.60
+128.36%
29.60
Research And Development
8.86
-25.21%
11.84
-41.66%
20.30
+66.38%
12.20
Selling General And Administration
35.22
-40.12%
58.82
+24.35%
47.30
+171.79%
17.41
General And Administrative Expense
—
—
—
17.41
Other Gand A
—
—
—
17.41
Total Expenses
47.52
-35.27%
73.40
+7.40%
68.35
+125.36%
30.33
Operating Income
-11.94
+81.87%
-65.84
-4.13%
-63.22
-196.87%
-21.30
Total Operating Income As Reported
-12.19
+81.52%
-65.92
-0.24%
-65.76
-208.79%
-21.30
EBITDA
-9.36
+85.79%
-65.90
-5.95%
-62.20
-187.99%
-21.60
Normalized EBITDA
-10.23
+83.80%
-63.17
-5.88%
-59.66
-195.93%
-20.16
Reconciled Depreciation
0.78
-38.46%
1.27
+51.79%
0.84
+16.43%
0.72
EBIT
-10.14
+84.90%
-67.17
-6.56%
-63.03
-182.47%
-22.32
Total Unusual Items
0.87
+131.82%
-2.73
-7.65%
-2.54
-76.55%
-1.44
Total Unusual Items Excluding Goodwill
0.87
+131.82%
-2.73
-7.65%
-2.54
-76.55%
-1.44
Special Income Charges
-1.78
-2043.37%
-0.08
+96.73%
-2.54
-76.55%
-1.44
Other Special Charges
1.53
—
—
1.44
Net Income
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Pretax Income
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Net Non Operating Interest Income Expense
-6.81
+14.78%
-8.00
-554.26%
-1.22
+27.95%
-1.70
Interest Expense Non Operating
7.74
-17.74%
9.41
+137.56%
3.96
+82.41%
2.17
Net Interest Income
-6.81
+14.78%
-8.00
-554.26%
-1.22
+27.95%
-1.70
Interest Expense
7.74
-17.74%
9.41
+137.56%
3.96
+82.41%
2.17
Interest Income Non Operating
0.93
-34.44%
1.42
-48.28%
2.74
+475.63%
0.48
Interest Income
0.93
-34.44%
1.42
-48.28%
2.74
+475.63%
0.48
Other Income Expense
0.87
+131.51%
-2.75
-7.72%
-2.55
-70.64%
-1.50
Other Non Operating Income Expenses
-0.00
+82.35%
-0.02
-21.43%
-0.01
+75.86%
-0.06
Gain On Sale Of Security
2.65
+200.00%
-2.65
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Net Income From Continuing Operation Net Minority Interest
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Net Income From Continuing And Discontinued Operation
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Net Income Continuous Operations
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Normalized Income
-18.75
+74.60%
-73.85
-14.57%
-64.46
-179.64%
-23.05
Net Income Common Stockholders
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Diluted EPS
—
-14.80
+0.00%
-14.80
-105.56%
-7.20
Basic EPS
—
-14.80
+0.00%
-14.80
-105.56%
-7.20
Basic Average Shares
—
5.18
+14.26%
4.53
+32.72%
3.42
Diluted Average Shares
—
5.18
+14.26%
4.53
+32.72%
3.42
Diluted NI Availto Com Stockholders
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Gain On Sale Of PPE
-0.25
-196.39%
-0.08
+96.73%
-2.54
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
47.13
-12.94%
54.13
-33.66%
81.60
+82.46%
44.72
Current Assets
42.54
-16.88%
51.18
-33.99%
77.53
+98.21%
39.12
Cash Cash Equivalents And Short Term Investments
30.15
-34.93%
46.33
-33.38%
69.55
+102.92%
34.27
Cash And Cash Equivalents
30.15
-34.93%
46.33
-33.38%
69.55
+102.92%
34.27
Other Short Term Investments
—
—
—
0.00
Receivables
5.40
+6909.09%
0.08
-98.26%
4.42
+806.78%
0.49
Accounts Receivable
5.26
+10858.33%
0.05
-98.87%
4.25
+994.85%
0.39
Other Receivables
0.14
+372.41%
0.03
-82.74%
0.17
+69.70%
0.10
Inventory
2.24
-9.22%
2.46
+141.00%
1.02
0.00
Raw Materials
0.97
-9.98%
1.08
+157.62%
0.42
0.00
Work In Process
0.78
+18.07%
0.66
+36.34%
0.49
0.00
Finished Goods
0.48
-33.33%
0.72
+523.48%
0.12
0.00
Prepaid Assets
—
—
—
—
Current Deferred Assets
1.96
0.00
—
—
Other Current Assets
2.80
+21.26%
2.31
-9.23%
2.54
-41.56%
4.36
Total Non Current Assets
4.59
+55.40%
2.96
-27.34%
4.07
-27.45%
5.61
Net PPE
1.86
-27.80%
2.58
-28.66%
3.62
-32.18%
5.33
Gross PPE
2.91
-24.11%
3.84
-19.88%
4.79
-20.57%
6.03
Accumulated Depreciation
-1.05
+16.53%
-1.26
-7.16%
-1.17
-67.95%
-0.70
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.54
-35.41%
0.84
-27.81%
1.16
-19.75%
1.44
Machinery Furniture Equipment
1.21
-32.79%
1.79
-17.45%
2.17
+8.82%
2.00
Construction In Progress
—
—
0.00
-100.00%
2.54
Other Properties
1.11
-3.55%
1.15
-17.86%
1.41
—
Leases
0.05
+0.00%
0.05
+0.00%
0.05
+0.00%
0.05
Non Current Deferred Assets
2.35
0.00
—
—
Other Non Current Assets
0.38
+0.00%
0.38
-16.81%
0.45
+63.77%
0.28
Total Liabilities Net Minority Interest
22.39
-65.02%
63.99
+3.49%
61.83
+1218.98%
4.69
Current Liabilities
16.44
-43.34%
29.01
+70.42%
17.02
+392.17%
3.46
Payables And Accrued Expenses
4.46
+17.10%
3.81
-47.66%
7.29
+313.22%
1.76
Payables
2.07
+9.28%
1.90
-23.05%
2.46
+386.00%
0.51
Accounts Payable
2.07
+9.28%
1.90
-23.05%
2.46
+386.00%
0.51
Current Accrued Expenses
2.39
+24.83%
1.92
-60.24%
4.82
+283.84%
1.26
Pensionand Other Post Retirement Benefit Plans Current
1.76
+50.30%
1.17
-65.88%
3.44
+145.75%
1.40
Current Debt And Capital Lease Obligation
0.75
-94.52%
13.61
+1843.57%
0.70
+135.69%
0.30
Current Debt
—
12.94
—
—
Other Current Borrowings
—
12.94
—
—
Current Capital Lease Obligation
0.75
+11.84%
0.67
-4.71%
0.70
+135.69%
0.30
Current Deferred Liabilities
0.78
0.00
—
—
Current Deferred Revenue
0.78
0.00
—
—
Other Current Liabilities
0.12
+13.33%
0.10
-56.97%
0.24
—
Total Non Current Liabilities Net Minority Interest
5.95
-82.99%
34.98
-21.93%
44.81
+3546.05%
1.23
Long Term Debt And Capital Lease Obligation
0.89
-97.26%
32.33
-27.84%
44.81
+3546.05%
1.23
Long Term Debt
—
30.98
-27.73%
42.87
—
Long Term Capital Lease Obligation
0.89
-34.49%
1.35
-30.22%
1.94
+57.53%
1.23
Other Non Current Liabilities
5.07
—
—
—
Stockholders Equity
24.74
+350.94%
-9.86
-149.89%
19.76
-50.63%
40.03
Common Stock Equity
24.74
+350.94%
-9.86
-149.89%
19.76
-50.63%
40.03
Capital Stock
0.00
+100.00%
0.00
-75.00%
0.00
+0.00%
0.00
Common Stock
0.00
+100.00%
0.00
-75.00%
0.00
+0.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
17.19
+87.07%
9.19
+116.11%
4.25
+3.20%
4.12
Ordinary Shares Number
17.18
+87.17%
9.18
+116.39%
4.24
+3.21%
4.11
Treasury Shares Number
0.01
+0.00%
0.01
+0.00%
0.01
+0.00%
0.01
Additional Paid In Capital
349.65
+17.66%
297.17
+18.77%
250.21
+22.96%
203.48
Retained Earnings
-324.91
-5.83%
-307.03
-33.23%
-230.45
-40.99%
-163.45
Gains Losses Not Affecting Retained Earnings
—
—
—
0.00
Treasury Stock
0.00
0.00
0.00
0.00
Other Equity Adjustments
—
—
—
—
Total Equity Gross Minority Interest
24.74
+350.94%
-9.86
-149.89%
19.76
-50.63%
40.03
Total Capitalization
24.74
+17.14%
21.12
-66.28%
62.64
+56.46%
40.03
Working Capital
26.10
+17.75%
22.17
-63.36%
60.51
+69.69%
35.66
Invested Capital
24.74
-27.36%
34.06
-45.62%
62.64
+56.46%
40.03
Total Debt
1.63
-96.45%
45.94
+0.94%
45.51
+2882.31%
1.53
Net Debt
—
—
—
—
Capital Lease Obligations
1.63
-19.18%
2.02
-23.44%
2.64
+72.74%
1.53
Net Tangible Assets
24.74
+350.94%
-9.86
-149.89%
19.76
-50.63%
40.03
Tangible Book Value
24.74
+350.94%
-9.86
-149.89%
19.76
-50.63%
40.03
Current Provisions
8.56
-17.00%
10.32
+92.57%
5.36
—
Derivative Product Liabilities
0.00
-100.00%
2.65
0.00
—
Interest Payable
—
—
—
0.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-17.63
+71.07%
-60.93
-57.94%
-38.58
-106.85%
-18.65
Cash Flow From Continuing Operating Activities
-17.63
+71.07%
-60.93
-57.94%
-38.58
-106.85%
-18.65
Net Income From Continuing Operations
-17.89
+76.64%
-76.58
-14.31%
-67.00
-173.59%
-24.49
Depreciation Amortization Depletion
0.78
-38.46%
1.27
+51.79%
0.84
+16.43%
0.72
Depreciation
0.78
-38.46%
1.27
+51.79%
0.84
+16.43%
0.72
Depreciation And Amortization
0.78
-38.46%
1.27
+51.79%
0.84
+16.43%
0.72
Other Non Cash Items
3.28
+48.73%
2.21
+172.35%
0.81
+108.23%
0.39
Stock Based Compensation
3.32
-53.69%
7.16
-50.17%
14.38
+188.39%
4.99
Asset Impairment Charge
0.00
-100.00%
0.26
0.00
—
Operating Gains Losses
-0.87
-131.82%
2.73
+7.65%
2.54
+76.55%
1.44
Gain Loss On Investment Securities
-2.65
-200.00%
2.65
—
—
Gain Loss On Sale Of PPE
0.25
+196.39%
0.08
-96.73%
2.54
0.00
Change In Working Capital
-6.25
-408.44%
2.03
-79.44%
9.86
+647.72%
-1.80
Change In Receivables
-5.32
-222.61%
4.34
+210.44%
-3.93
-706.78%
-0.49
Changes In Account Receivables
-5.21
-224.10%
4.20
+208.81%
-3.86
0.00
Change In Prepaid Assets
-0.26
+76.60%
-1.13
-292.16%
0.59
+228.73%
-0.46
Change In Payables And Accrued Expense
-1.14
-31.67%
-0.86
-106.39%
13.49
+2375.21%
-0.59
Change In Accrued Expense
-1.31
-345.92%
-0.29
-102.60%
11.29
+4527.84%
-0.26
Change In Payable
0.18
+130.99%
-0.57
-125.81%
2.20
+751.18%
-0.34
Change In Account Payable
0.18
+130.99%
-0.57
-125.81%
2.20
+751.18%
-0.34
Change In Other Working Capital
0.78
—
—
—
Change In Other Current Liabilities
-0.32
+2.17%
-0.32
-10.65%
-0.29
-10.23%
-0.26
Investing Cash Flow
0.00
+100.00%
-0.02
+94.75%
-0.36
-100.67%
54.04
Cash Flow From Continuing Investing Activities
0.00
+100.00%
-0.02
+94.75%
-0.36
-100.67%
54.04
Net PPE Purchase And Sale
0.00
+100.00%
-0.02
+94.75%
-0.36
-19.87%
-0.30
Purchase Of PPE
0.00
+100.00%
-0.03
+92.54%
-0.36
-19.87%
-0.30
Sale Of PPE
0.00
-100.00%
0.01
0.00
—
Capital Expenditure
—
-0.03
+92.54%
-0.36
-19.87%
-0.30
Net Investment Purchase And Sale
—
—
0.00
-100.00%
54.34
Purchase Of Investment
—
—
0.00
+100.00%
-4.67
Sale Of Investment
—
—
0.00
-100.00%
59.01
Net Other Investing Changes
—
—
—
-0.18
Financing Cash Flow
1.45
-96.17%
37.73
-49.16%
74.21
+539.91%
-16.87
Cash Flow From Continuing Financing Activities
1.45
-96.17%
37.73
-49.16%
74.21
+539.91%
-16.87
Net Issuance Payments Of Debt
-48.20
-5116.67%
-0.92
-102.10%
44.08
+200.75%
-43.75
Issuance Of Debt
0.00
0.00
-100.00%
44.10
0.00
Repayment Of Debt
-48.20
-5116.67%
-0.92
-3917.39%
-0.02
+99.95%
-43.75
Long Term Debt Issuance
0.00
0.00
-100.00%
44.10
0.00
Long Term Debt Payments
-48.20
-5116.67%
-0.92
-3917.39%
-0.02
+99.95%
-43.75
Net Long Term Debt Issuance
-48.20
-5116.67%
-0.92
-102.10%
44.08
+200.75%
-43.75
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
-43.75
Net Short Term Debt Issuance
—
—
—
-43.75
Net Common Stock Issuance
50.07
+17.80%
42.50
+40.27%
30.30
+12.64%
26.90
Proceeds From Stock Option Exercised
0.00
-100.00%
0.15
+2114.29%
0.01
0.00
Net Other Financing Charges
-0.42
+89.51%
-4.00
-2175.00%
-0.18
-935.29%
-0.02
Changes In Cash
-16.18
+30.30%
-23.22
-165.82%
35.27
+90.45%
18.52
Beginning Cash Position
46.33
-33.38%
69.55
+102.92%
34.27
+117.58%
15.75
End Cash Position
30.15
-34.93%
46.33
-33.38%
69.55
+102.92%
34.27
Free Cash Flow
-17.63
+71.08%
-60.95
-56.54%
-38.94
-105.46%
-18.95
Interest Paid Supplemental Data
5.17
-28.43%
7.22
+129.22%
3.15
+76.19%
1.79
Amortization Of Securities
—
—
0.00
-100.00%
0.11
Common Stock Issuance
50.07
+17.80%
42.50
+40.27%
30.30
+12.64%
26.90
Issuance Of Capital Stock
50.07
+17.80%
42.50
+40.27%
30.30
+12.64%
26.90
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category